Hyperlipoproteinemia(a) as a dangerous genetically determined violation of lipid metabolism and a risk factor for atherothrombosis and cardiovascular diseases

by O. I. Afanasieva, S. N. Pokrovsky
Published 2019-06-01

LIPID METABOLISM CORRECTION BY ANTISENSE TECHNOLOGY

by O. I. Afanasieva, S. N. Pokrovsky
Published 2015-09-01

LIPID METABOLISM CORRECTION BY ANTISENSE TECHNOLOGY

by O. I. Afanasieva, S. N. Pokrovsky
Published 2015-09-01

Opportunities for immunocorrection aiming for reduction of morbidity in the areas with adverse occupational and environmental conditions

by S. V. Petlenko, E. G. Golovacheva, O. I. Afanasieva
Published 2021-01-01

ANTISENSE OLIGONUCLEOTIDES AND THERAPEUTICAL MONOCLONAL ANTIBODIES AS A BASEMENT FOR NOVEL BIOLOGICAL LIPIDLOWERING DRUGS

by O. I. Afanasieva, M. V. Ezhov, S. N. Pokrovsky
Published 2018-09-01

The heterogeneity of lipoproteins and their role in the development of cardiovascular diseases

by E. A. Utkina, O. I. Afanasieva, S. N. Pokrovsky
Published 2019-06-01

Effect of atorvastatin and rosuvastatin on the PCSK9 blood concentration in statin-naive patients with atherosclerosis

by A. Yu. Filatova, T. I. Arefieva, E. A. Klesareva, O. I. Afanasieva
Published 2019-06-01

INFLUENCE OF NICOTINIC ACID ON SUBFRACTIONAL SPECTRUM OF LOW, INTERMEDIATE AND HIGH DENSITY LIPOPROTEINS IN PATIENTS WITH HYPERLIPOPROTEINEMIA(а)

by E. A. Utkina, O. I. Afanasieva, N. V. Artemyeva, M. V. Ezhov, S. N. Pokrovsky
Published 2017-06-01

CORRELATIONS OF LOW MOLECULAR WEIGHT PHENOTYPE OF APOPROTEIN(A) AND SERUM LEVEL OF LIPOPROTEIN(A) WITH MULTIFOCAL ATHEROSCLEROSIS IN PATIENTS WITH CORONARY HEART DISEASE

by O. I. Afanasieva, M. V. Ezhov, M. I. Afanasieva, M. S. Safarova, J. V. Berestetskaya, S. N. Pokrovsky
Published 2016-01-01

Severe hyperlipoproteinemia(a) as a factor of rapidly progressive coronary artery disease in a young woman with heterozygous familial hypercholesterolemia

by U. V. Chubykina, O. I. Afanasieva, N. T. Khachatryan, N. G. Kukava, V. P. Vasiliev, M. V. Ezhov
Published 2019-06-01

SUBFRACTIONS OF ATHEROGENIC APOB-LIPOPROTEIDES IN PATIENTS WITH SEVERE HYPERCHOLESTEROLEMIA

by E. A. Utkina, O. I. Afanasieva, M. I. Afanasieva, A. B. Popova, M. V. Ezhov, S. N. Pokrovsky
Published 2017-08-01

THE DYNAMICS OF THE IMMUNE RESPONSEМ TO INFLUENZA IN CHILDREN TREATED WITH INTERFERON

by E. G. Golovacheva, V. S. Afanasyeva, L. V. Osidak, O. I. Afanasieva, E. V. Obraztsova, E. G. Koroleva, V. N. Timchenko
Published 2017-03-01

The association of lipoprotein(a) and apolipoprotein(a) phenotypes with peripheral artery disease

by N A Tmoyan, M V Ezhov, O I Afanasieva, E A Klesareva, O A Razova, V V Kukharchuk, S N Pokrovsky
Published 2018-09-01

RAISED IgM AUTOANTIBODY TITER TO LIPOPROTEIDE(A) AS ANTIATHEROGENIC FACTOR IN SEVERE HYPERCHOLESTEROLEMIA PATIENTS

by E. A. Klesareva, O. I. Afanasieva, E. V. Kononova, E. A. Utkina, M. V. Ezhov, T. V. Balakhonova, M. I. Afanasieva, S. N. Pokrovsky
Published 2018-09-01